Related Articles
Childhood thyroid carcinoma with BRAFT1799A mutation shows unique pathological features of poor differentiation
Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules
PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms
Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas
Signaling pathways in follicular cell-derived thyroid carcinomas (Review)